Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biotalys NV's Days Sales Outstanding for the
six
months ended in Dec. 2025 was .
Biotalys NV's Days Inventory for the
six
months ended in Dec. 2025 was .
Biotalys NV's Days Payable for the
six
months ended in Dec. 2025 was .
Therefore, Biotalys NV's Cash Conversion Cycle (CCC) for the
six
months ended in Dec. 2025 was 0.00.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Biotalys NV Cash Conversion Cycle Related Terms
Biotalys NV Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Biotalys NV's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:86C vs CTVA, CF, MOS: Cash Conversion Cycle Comparison
For the Agricultural Inputs subindustry, Biotalys NV's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biotalys NV Cash Conversion Cycle vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Biotalys NV's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Biotalys NV's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Biotalys NV's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotalys NV (FRA:86C) has a Cash Conversion Cycle of 0.00 as of Dec. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Biotalys NV and its competitors.
Is Biotalys NV's Cash Conversion Cycle too high?
Biotalys NV's current Cash Conversion Cycle is 0.00. Overall, Biotalys NV has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Biotalys NV's Cash Conversion Cycle compare to CTVA and CF?
Biotalys NV's Cash Conversion Cycle of 0.00 can be compared against companies in the Agriculture industry. The industry median Cash Conversion Cycle is 98.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for an Agriculture company?
The median Cash Conversion Cycle among Agriculture companies is 98.55, based on 249 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Biotalys NV and its competitors. For the Agriculture industry, the median Cash Conversion Cycle is 98.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biotalys NV's current Cash Conversion Cycle is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotalys NV stock overvalued right now?
Biotalys NV (FRA:86C) has a current Cash Conversion Cycle of 0.00. The current Cash Conversion Cycle is 0.00. Biotalys NV's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Biotalys NV (FRA:86C), the current Cash Conversion Cycle is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biotalys NV is an Agricultural Technology (AgTech) company developing Precision Biocontrol solutions based on proteins for the protection of crops in both the pre and post harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Its pipeline EVOCA 1st Gen, EVOCA NG, BioFun-6, and BioFun-7. It operates in single segment.
37GF Score
Get the complete analysis for FRA:86C
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:86C has been successfully added to your 
